These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10707848)

  • 21. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the zebrafish intermediate neurofilament Nestin in the developing nervous system and in neural proliferation zones at postembryonic stages.
    Mahler J; Driever W
    BMC Dev Biol; 2007 Jul; 7():89. PubMed ID: 17651502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
    Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia.
    Chowers I; Livni N; Solomon A; Zajicek G; Frucht-Pery J; Folberg R; Pe'er J
    Br J Ophthalmol; 1998 Nov; 82(11):1316-9. PubMed ID: 9924341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma].
    Urpegui García AM; Morandeira García MJ; Soria Navarro J; Rivas Rodríguez P; Valencia Julve J; Fernández Larripa S; Vallés Varela H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):279-87. PubMed ID: 10984949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of cellular proliferation in the developing human retina.
    Smirnov EB; Puchkov VF
    Neurosci Behav Physiol; 2004 Jul; 34(6):643-8. PubMed ID: 15368915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
    Wang W; Bergh A; Damber JE
    Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The evaluation of cell proliferation in gliomas].
    Alkiza K; Adán B; Garibi JM; Lafuente JV
    Rev Neurol; 2000 Jan 16-31; 30(2):141-6. PubMed ID: 10730321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma?
    Guimarães GC; Leal ML; Campos RS; Zequi Sde C; da Fonseca FP; da Cunha IW; Soares FA; Lopes A
    Urology; 2007 Jul; 70(1):137-42. PubMed ID: 17656224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells.
    Endl E; Kausch I; Baack M; Knippers R; Gerdes J; Scholzen T
    J Pathol; 2001 Nov; 195(4):457-62. PubMed ID: 11745678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathology.
    Wharton SB; Williams GH; Stoeber K; Gelsthorpe CH; Baxter L; Johnson AL; Ince PG;
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):33-8. PubMed ID: 15936508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemia induced changes in cell death and cell proliferation in the organogenesis stage embryonic mouse heart.
    Ghatnekar GS; Barnes JA; Dow JL; Smoak IW
    Birth Defects Res A Clin Mol Teratol; 2004 Mar; 70(3):121-31. PubMed ID: 15039926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.
    Dixon D; Flake GP; Moore AB; He H; Haseman JK; Risinger JI; Lancaster JM; Berchuck A; Barrett JC; Robboy SJ
    Virchows Arch; 2002 Jul; 441(1):53-62. PubMed ID: 12111201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prolipherative and proapoptotic activity of limfoid nodules cells in the hypertrophic pharyngeal tonsil].
    Szczepański M; Gryko A; Kamianowska M; Dziecioł J
    Pol Merkur Lekarski; 2008 Dec; 25(150):484-8. PubMed ID: 19205378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.